Source: Eur Respir J 2004; 23: 440-445
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nusair S., Breuer R., Shapira M.Y., Berkman N., Or R.. Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J 2004; 23: 440-445

Member's Comments

No comment yet.

Related content which might interest you: Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005 Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study Source: Eur Respir J 2005; 25: 490-493 Year: 2005 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Late idiopathic pneumonia syndrome after hematopoietic bone marrow transplantation: prognosis remains poor despite the use of etanercept Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008 Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018 Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation Source: Eur Respir J 2014; 43: 221-232 Year: 2004 Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006